Patient Preferences and Linear Scoring Rules for Patient-Reported Outcomes
<Emphasis Type="Bold">Background: Many patient-reported outcomes (PRO) instruments are scored by averaging or summing Likert category values over all items or domains of the elicitation instrument, yielding domain-specific scores or a total score for the entire instrument. <Emphasis Type="Bold">Objective: To evaluate differences between conventional linear and preference-weighted scores for PRO instruments used in asthma, oncology, and obesity. <Emphasis Type="Bold">Methods: We estimated preference-weighted scores for all the items and response categories in the Onset-of-Effect Questionnaire (OEQ), the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30, and the Impact of Weight on Quality of Life Questionnaire-Lite version (IWQOL-Lite) using choice-format conjoint analysis, known also as discrete-choice experiments. <Emphasis Type="Bold">Results: Conventional linear scoring rules can overstate the relative importance to patients of improvements in some domains and understate the relative importance of improvements in other domains. <Emphasis Type="Bold">Conclusions: Patient preference-weighted scores estimated by conjoint-analysis methods allow for non-linearities and account for the relative contribution of individual items and domains to patient well-being. Conventional linear scores and preference-weighted scores can result in different conclusions about the size of patient-reported treatment effects. Copyright Adis Data Information BV 2010
Year of publication: |
2010
|
---|---|
Authors: | Mohamed, Ateesha ; Hauber, A. Brett ; Johnson, F. ; Coon, Cheryl |
Published in: |
The Patient: Patient-Centered Outcomes Research. - Springer, ISSN 0889-048X. - Vol. 3.2010, 4, p. 217-227
|
Publisher: |
Springer |
Saved in:
Saved in favorites
Similar items by person
-
US FDA patient-reported outcome guidance: great expectations and unintended consequences
Fehnel, Sheri, (2013)
-
Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma
Mohamed, Ateesha, (2011)
-
Kauf, Teresa, (2012)
- More ...